These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10969140)

  • 1. Contribution of the renin-angiotensin system to subsensitivity of soluble guanylyl cyclase in TGR(mREN2)27 rats.
    Jacke K; Witte K; Huser L; Behrends S; Lemmer B
    Eur J Pharmacol; 2000 Sep; 403(1-2):27-35. PubMed ID: 10969140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways.
    Witte K; Huser L; Knotter B; Heckmann M; Schiffer S; Lemmer B
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):101-9. PubMed ID: 11191827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms involved in the blunted nitric oxide-cGMP pathway in hypertensive TGR(mREN2)27 rats.
    Jacke K; Witte K; Lemmer B
    Eur J Pharmacol; 2001 Mar; 415(1):27-30. PubMed ID: 11245848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction in cardiac and vascular tissue from normotensive and transgenic hypertensive TGR(mREN2)27 rats.
    Witte K; Schnecko A; Perbandt K; Höfer S; Lemmer B
    Eur J Pharmacol; 1998 Jan; 341(2-3):337-41. PubMed ID: 9543257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase.
    Klöss S; Bouloumié A; Mülsch A
    Hypertension; 2000 Jan; 35(1 Pt 1):43-7. PubMed ID: 10642273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats.
    Ohta K; Kim S; Wanibuchi H; Ganten D; Iwao H
    Circulation; 1996 Aug; 94(4):785-91. PubMed ID: 8772703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of vascular natriuretic peptide receptors in experimental hypertensive rats.
    Lee J; Kim S; Jung M; Oh Y; Kim SW
    Clin Exp Pharmacol Physiol; 2002 Apr; 29(4):299-303. PubMed ID: 11985539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats.
    Bader M; Zhao Y; Sander M; Lee MA; Bachmann J; Böhm M; Djavidani B; Peters J; Mullins JJ; Ganten D
    Hypertension; 1992 Jun; 19(6 Pt 2):681-6. PubMed ID: 1592468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of inverse circadian blood pressure pattern in transgenic hypertensive TGR(mREN2)27 rats.
    Witte K; Lemmer B
    Chronobiol Int; 1999 May; 16(3):293-303. PubMed ID: 10373099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene.
    Springate J; Van Liew J; Ganten D
    Kidney Blood Press Res; 1997; 20(1):1-5. PubMed ID: 9192903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
    Fedele E; Jin Y; Varnier G; Raiteri M
    Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats. TGR(mREN2)27.
    Peters J; Hilgers KF; Maser-Gluth C; Kreutz R
    Clin Exp Hypertens; 1996 Oct; 18(7):933-48. PubMed ID: 8886477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production.
    Bauersachs J; Bouloumié A; Mülsch A; Wiemer G; Fleming I; Busse R
    Cardiovasc Res; 1998 Mar; 37(3):772-9. PubMed ID: 9659462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
    Reyna-Neyra A; Sarkar G; Etgen AM
    J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the nitric oxide-guanylyl cyclase system to circadian regulation of blood pressure in normotensive Wistar-Kyoto rats.
    Witte K; Schnecko A; Zuther P; Lemmer B
    Cardiovasc Res; 1995 Nov; 30(5):682-8. PubMed ID: 8595613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of circadian time and age on glomerular angiotensin II receptors in normotensive Sprague-Dawley and transgenic hypertensive TGR(mREN2)27 rats.
    Lemmer B; Rueff T; Reiter S; Huser L; Hauptfleisch S; Witte K
    Chronobiol Int; 2001 May; 18(3):447-59. PubMed ID: 11475415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model.
    Bachmann S; Peters J; Engler E; Ganten D; Mullins J
    Kidney Int; 1992 Jan; 41(1):24-36. PubMed ID: 1593860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.